Patents by Inventor Jonathan S. Till
Jonathan S. Till has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9204996Abstract: This invention effects a change in the accommodation of the human lens affected by presbyopia through the use of various reducing agents that change accommodative abilities of the human lens, and/or by applying energy to affect a change in the accommodative abilities of the human lens. This invention both prevents the onset of presbyopia as well as treats it. By breaking and/or preventing the formation of bonds that adhere lens fibers together causing hardening of the lens, the present invention increases the elasticity and distensibility of the lens and/or lens capsule.Type: GrantFiled: May 12, 2014Date of Patent: December 8, 2015Assignee: Encore Health, LLCInventors: Jonathan S. Till, Ronald D. Blum
-
Publication number: 20140336562Abstract: This invention effects a change in the accommodation of the human lens affected by presbyopia through the use of various reducing agents that change accommodative abilities of the human lens, and/or by applying energy to affect a change in the accommodative abilities of the human lens. This invention both prevents the onset of presbyopia as well as treats it. By breaking and/or preventing the formation of bonds that adhere lens fibers together causing hardening of the lens, the present invention increases the elasticity and distensibility of the lens and/or lens capsule.Type: ApplicationFiled: May 12, 2014Publication date: November 13, 2014Applicant: Encore Health, LLCInventors: Jonathan S. TILL, Ronald D. Blum
-
Patent number: 8747829Abstract: This invention effects a change in the accommodation of the human lens affected by presbyopia through the use of various reducing agents that change accommodative abilities of the human lens, and/or by applying energy to affect a change in the accommodative abilities of the human lens. This invention both prevents the onset of presbyopia as well as treats it. By breaking and/or preventing the formation of bonds that adhere lens fibers together causing hardening of the lens, the present invention increases the elasticity and distensibility of the lens and/or lens capsule.Type: GrantFiled: February 16, 2011Date of Patent: June 10, 2014Assignee: Encore Health, LLCInventors: Jonathan S. Till, Ronald D. Blum
-
Patent number: 8147816Abstract: Embodiments of the present invention relate to methods and pharmacological or biological compositions to treat presbyopia in the human eye. According to the embodiments, pharmacological or biological compositions may be applied to or injected into an eye to effect a change in the accommodative ability of the eye by the breaking and reduction of lenticular bonds in the eye that may be responsible for presbyopia. The compositions may be applied in an inactive state and subsequently be activated to achieve a therapeutic effect. The application of energy may be used to either break the oxidized lenticular bonds and/or to activate one or more of the pharmacological or biological agents. The energy may be used in a focus treatment pattern to affect a change in the refractive characteristics of the eye and thereby reduce inherent optical distortions.Type: GrantFiled: November 28, 2007Date of Patent: April 3, 2012Assignee: Encore Health, LLCInventors: Jonathan S. Till, Ronald D. Blum, William R. Burns
-
Publication number: 20110135622Abstract: This invention effects a change in the accommodation of the human lens affected by presbyopia through the use of various reducing agents that change accommodative abilities of the human lens, and/or by applying energy to affect a change in the accommodative abilities of the human lens. This invention both prevents the onset of presbyopia as well as treats it. By breaking and/or preventing the formation of bonds that adhere lens fibers together causing hardening of the lens, the present invention increases the elasticity and distensibility of the lens and/or lens capsule.Type: ApplicationFiled: February 16, 2011Publication date: June 9, 2011Applicant: Encore Health, LLCInventors: Jonathan S. Till, Ronald D. Blum
-
Patent number: 7935332Abstract: This invention effects a change in the accommodation of the human lens affected by presbyopia through the use of various reducing agents that change accommodative abilities of the human lens, and/or by applying energy to affect a change in the accommodative abilities of the human lens. This invention both prevents the onset of presbyopia as well as treats it. By breaking and/or preventing the formation of bonds that adhere lens fibers together causing hardening of the lens, the present invention increases the elasticity and distensibility of the lens and/or lens capsule.Type: GrantFiled: December 14, 2004Date of Patent: May 3, 2011Assignee: Encore Health, LLCInventor: Jonathan S. Till
-
Patent number: 7914815Abstract: Embodiments of the present invention relate to a method for delivering pharmaceuticals to the lens of the eye to treat or prevent presbyopia. According to the embodiments, pharmaceuticals may be applied by providing the pharmaceuticals to the eye and promoting delivery of the pharmaceuticals into the lens capsule and/or lens fibers of the lens of the eye. Methods include iontophoresis, nano-medication, and photonic activation to deliver the pharmaceuticals to treat or prevent presbyopia.Type: GrantFiled: May 24, 2005Date of Patent: March 29, 2011Assignee: Encore Health, LLCInventors: Jonathan S. Till, Ronald D. Blum, William Kokonaski, Dwight P. Duston
-
Publication number: 20080139990Abstract: Embodiments of the present invention relate to methods and pharmacological or biological compositions to treat presbyopia in the human eye. According to the embodiments, pharmacological or biological compositions may be applied to or injected into an eye to effect a change in the accommodative ability of the eye by the breaking and reduction of lenticular bonds in the eye that may be responsible for presbyopia. The compositions may be applied in an inactive state and subsequently be activated to achieve a therapeutic effect. The application of energy may be used to either break the oxidized lenticular bonds and/or to activate one or more of the pharmacological or biological agents. The energy may be used in a focus treatment pattern to affect a change in the refractive characteristics of the eye and thereby reduce inherent optical distortions.Type: ApplicationFiled: November 28, 2007Publication date: June 12, 2008Applicant: Encore Health, LLCInventors: Jonathan S. Till, Ronald D. Blum, William R. Burns
-
Patent number: 6923955Abstract: This invention effects a change in the accommodation of the human lens affected by presbyopia through the use of various reducing agents that change accommodative abilities of the human lens, and/or by applying energy to affect a change in the accommodative abilities of the human lens. This invention both prevents the onset of presbyopia as well as treats it. By breaking and/or preventing the formation of bonds that adhere lens fibers together causing hardening of the lens, the present invention increases the elasticity and distensibility of the lens and/or lens capsule.Type: GrantFiled: January 18, 2002Date of Patent: August 2, 2005Assignee: Newlens, LLCInventors: Jonathan S. Till, Ronald D. Blum
-
Publication number: 20040213774Abstract: This invention effects a change in the accommodation of the human lens affected by presbyopia through the use of various reducing agents that change accommodative abilities of the human lens, and/or by applying energy to affect a change in the accommodative abilities of the human lens. This invention both prevents the onset of presbyopia as well as treats it. By breaking and/or preventing the formation of bonds that adhere lens fibers together causing hardening of the lens, the present invention increases the elasticity and distensibility of the lens and/or lens capsule.Type: ApplicationFiled: January 18, 2002Publication date: October 28, 2004Inventor: Jonathan S. Till
-
Publication number: 20020138139Abstract: The invention discloses methods and apparatus that reverse or eliminate presbyopia by affecting a change in the shape of the sclera. The change can be designed to reduce tension placed on the lens from the zonules, thereby allowing the lens to bulge about its central axis.Type: ApplicationFiled: March 22, 2002Publication date: September 26, 2002Inventor: Jonathan S. Till
-
Publication number: 20020110549Abstract: This invention effects a change in the accommodation of the human lens affected by presbyopia through the use of various reducing agents that change accommodative abilities of the human lens, and/or by applying energy to affect a change in the accommodative abilities of the human lens. This invention both prevents the onset of presbyopia as well as treats it. By breaking and/or preventing the formation of bonds that adhere lens fibers together causing hardening of the lens, the present invention increases the elasticity and distensibility of the lens and/or lens capsule.Type: ApplicationFiled: January 18, 2002Publication date: August 15, 2002Inventor: Jonathan S. Till
-
Publication number: 20020025311Abstract: This invention effects a change in the accommodation of the human lens affected by presbyopia through the use of various reducing agents that change accommodative abilities of the human lens, and/or by applying external energy to affect a change in the accommodative abilities of the human lens. By breaking bonds that adhere lens fibers together causing hardening of the lens, the present invention increases the elasticity and distensibility of the lens and/or lens capsule.Type: ApplicationFiled: August 16, 2001Publication date: February 28, 2002Inventor: Jonathan S. Till